| |
The Drug Discovery Portal (DDP) is based on a unique assembly of highly diverse compounds that are not otherwise commercially available. The compounds are initially used in silico for virtual screening, but they are linked to the originating chemists so that samples are available for physical screening and analogues can be rapidly designed and synthesised in order to understand structure-activity relationships. Hence, you can go quickly from a novel hit to an optimised candidate. The DDP is built on a combination of medicinal chemistry experience and advanced computational chemistry knowledge. Our researchers have extensive experience of the drug discovery process gained from both industrial and academic collaborations and an understanding of the molecular biology and biochemistry associated with molecular targets. Please contact us if you are interested in matching your compounds or targets for accelerated drug discovery, or if you simply wish to receive updates on our progress, contact-ddp@strath.ac.uk This facility is supported The University of Strathclyde with contributions from SULSA, National e-Science Centre and Scottish Enterprise |
|
| news |
Compound Collection approaches 14,600 The DDP Academic Compound Collection contains almost 14,557 compounds donated from 21 collaborating Universities world-wide..... more |
Virtual screening targets To date there are 14 drug targets available for virtual screening with corresponding assays in place within Strathclyde and collaborating labs .... more | | |
| meetings |
No meetings at present. Check back soon for the latest developments |
|